{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:33:40Z","timestamp":1793050420512,"version":"4.5.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34AI124954"],"award-info":[{"award-number":["R34AI124954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2019,1,2]]},"DOI":"10.1080\/14787210.2018.1555241","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T13:20:15Z","timestamp":1543670415000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":53,"title":["Oxfendazole: a promising agent for the treatment and control of helminth infections in humans"],"prefix":"10.1080","volume":"17","author":[{"given":"Armando E.","family":"Gonzalez","sequence":"first","affiliation":[{"name":"Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru"},{"name":"School of Veterinary Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen E.","family":"Codd","sequence":"additional","affiliation":[{"name":"Codd Consulting, LLC, Blue Bell, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[{"name":"Tropical Projects, Hitchin, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector H.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Gilman","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2009.11.001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70094-8"},{"key":"CIT0003","unstructured":"41-4-Oxfendazole. UN FAO web site 2003 [cited 2018 Jul 25]; Available from: https:\/\/web.archive.org\/web\/20170518153340\/ftp.fao.org\/ag\/agn\/jecfa\/vetdrug\/41-4-oxfendazole.pdf"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1177\/1091581815569582"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2000073221"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1136\/vr.103.15.332"},{"key":"CIT0007","unstructured":"FDA. Animal & Veterinary NADA 140-854 Synanthic\u00ae - original approval- summary. 1990; Available from: https:\/\/web.archive.org\/web\/20171115071339\/https:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/Products\/ApprovedAnimalDrugProducts\/FOIADrugSummaries\/UCM478234.pdf"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/BF00931659"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1995.53.571"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1996.54.391"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/vr.141.16.420"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2013.06.010"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.59.832"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.11-0371"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0370"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2015.12.005"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.74.850"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.15"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515520"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1007\/s11250-017-1474-6"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2016.03.012"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001651"},{"key":"CIT0023","volume-title":"Paranthic 10%-internal anthelminthic for cattle and swine, M.C.I","author":"M.C.I.-Sant\u00e9-Animale","year":"2015"},{"key":"CIT0024","unstructured":"WHO. (May 22, 2017) First ever licensed vaccine and anthelmintic against the major cause of epilepsy in the developing world. Neglected Tropical Diseases. Available from: http:\/\/www.who.int\/neglected_diseases\/news\/First-licensed-vaccine-and-anthelmintic-against-epilepsy\/en\/"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.601"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2009.80.367"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000616"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.11-0476"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtb.2015.03.013"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/BF02214711"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2007.06.028"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2012.07.023"},{"key":"CIT0033","unstructured":"Gow J Pharmacokinetics and bioavailability of oxfendazole in Sprague-Dawley rats. Menlo Park, CA: SRI International; 2010 November 3. (Report No. B381-10)."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006218"},{"key":"CIT0035","volume-title":"Abstract 2088, presented at the 67th Annual Meeting of the American Society of Tropical Medicne and Hygiene","author":"Hubner MP","year":"2018"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.30"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2018.1555241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:45:38Z","timestamp":1598744738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2018.1555241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,2]]}},"alternative-id":["10.1080\/14787210.2018.1555241"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2018.1555241","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}